|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/34724446/ Transplant J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):175-179. De Novo Food Allergy in Pediatric Recipients of Liver Transplant Francesca Mori 1, Mattia Giovannini 1 2, Simona Barni 1, Sandra Trapani 2, Giuseppe Indolfi 3 Abstract Published on:
Feb-2022
|
https://pubmed.ncbi.nlm.nih.gov/35082246/ Biliary atresia J Pediatr Gastroenterol Nutr. 2022 Jan 25. doi: 10.1097/MPG.0000000000003388.Online ahead of print. Quantification of Maternal Microchimeric Cells in the Liver of Children with Biliary Atresia Satoshi Tamaoka 1, Akinari Fukuda, Yuko Katoh-Fukui, Atsushi Hattori, Hajime Uchida, Seiichi Shimizu, Yusuke Yanagi, Sami B Kanaan, Seisuke Sakamoto, Mureo Kasahara, Takako Yoshioka, Maki Fukami Abstract Published on:
Jan-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/34695449/ J Pediatr. 2022 Feb;241:173-180.e1. Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events Kathleen M Gura 1, Kara L Calkins 2, Muralidhar H Premkumar 3, Mark Puder 4 Objective: To compare extrahepatic adverse events during fish oil lipid emulsion (FOLE) or soybean oil lipid emulsion (SOLE) treatment in children with intestinal failure-associated liver disease (IFALD). Published on:
Feb-2022
|
https://pubmed.ncbi.nlm.nih.gov/35141179/ transplant Front Pediatr. 2022 Jan 24;9:796504. Association Between Serum Lactate and Unsatisfactory Outcomes in Critically Ill Children in the Immediate Post-operative Period of Liver Transplantation Jaime Fernández-Sarmiento 1, María Angélica Wilches-Cuadros 2, Ricardo Hernandez-Sarmiento 1, Hernando Mulett 1, Karen Moreno-Medina 3, Nicolás Molano 4, Julián Augusto Palomar Dominguez 5, Lorena Acevedo 1, Claudia Salinas 6, Jairo Rivera 6 Abstract Published on:
Jan-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/34654793/ Covid-19 J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):e41-e42. SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European Experience Gustav Buescher 1 2, Marcial Sebode 1 2, Thomas Marjot 3, Gwilym J Webb 4, Andrew M Moon 5, Eleanor Barnes 3, Alfred S Barritt 4th 5, Mara Cananzi 2 6, Ansgar W Lohse 1 2, Marianne H Jørgensen 2 7, Valérie McLin 8 Published on:
Feb-2022
|
https://pubmed.ncbi.nlm.nih.gov/35068050/ liver transplant Am J Med Genet A. 2022 Jan 23. Inborn error of metabolism patients after liver transplantation: Outcomes of 35 patients over 27 years in one pediatric quaternary hospital Amanda Barone Pritchard 1, Kosuke Izumi 2, Irma Payan-Walters 2, Marc Yudkoff 2, Elizabeth B Rand 3, Elizabeth Bhoj 2 4 Abstract Published on:
Jan-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35155971/ Alagille J Endocr Soc. 2022 Jan 18;6(3):bvac005. A Case of Infantile Alagille Syndrome With Severe Dyslipidemia: New Insight into Lipid Metabolism and Therapeutics Hisakazu Nakajima 1 2, Yusuke Tsuma 1, Shota Fukuhara 1, Kazuki Kodo 1 Abstract Published on:
Jan-2022
|
https://pubmed.ncbi.nlm.nih.gov/35110951/ viral hepatitis World J Gastroenterol. 2022 Jan 21;28(3):290-309. Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030 Palittiya Sintusek 1, Kessarin Thanapirom 2, Piyawat Komolmit 2, Yong Poovorawan 3 Abstract Published on:
Jan-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35080454/ Autoimmune AJR Am J Roentgenol. 2022 Jan 26. Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease Joseph McCrary 1 2, Andrew T Trout 1 2 3, Neeraja Mahalingam 1, Ruchi Singh 4, Cyd Castro Rojas 4, Alexander G Miethke 3 4, Jonathan R Dillman 1 2 Published on:
Jan-2022
|
https://pubmed.ncbi.nlm.nih.gov/35064452/ NAFLD Indian J Gastroenterol. 2022 Jan 21. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors Srinivasan Thiagarajan 1, Sadhanandham Shrinuvasan 2, Thirunavukkarasu Arun Babu 3 Abstract Background: Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized in obese and overweight children. NAFLD is the commonest cause of chronic liver disease in these children. We undertook a study to assess the prevalence of NAFLD and to identify the associated anthropometric and metabolic risk factors. Published on:
Jan-2022
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
